blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1478338

EP1478338 - POWDER INHALATION CONTAINING CGRP-ANTAGONIST BIBN4096 AND METHOD FOR THE PRODUCTION THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.05.2006
Database last updated on 08.10.2024
Most recent event   Tooltip05.12.2008Lapse of the patent in a contracting state
New state(s): CY		published on 07.01.2009  [2009/02]
Applicant(s)For all designated states
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[N/P]
Former [2004/48]For all designated states
Boehringer Ingelheim Pharma GmbH & Co.KG
Binger Strasse 173
55216 Ingelheim am Rhein / DE
Inventor(s)01 / TRUNK, Michael
Im Brühl 5
55218 Ingelheim am Rhein / DE
02 / WEILER, Claudius
An der Selzer Mühle 28
55218 Ingelheim-Grosswinterheim / DE
 [2005/21]
Former [2004/48]01 / TRUNK, Michael
Selztalstrasse 44
55218 Ingelheim am Rhein / DE
02 / WEILER, Claudius
An der Selzer Mühle 28
55218 Ingelheim-Grosswinterheim / DE
Application number, filing date03706518.217.02.2003
[2004/48]
WO2003EP01563
Priority number, dateDE200210702620.02.2002         Original published format: DE 10207026
[2004/48]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO03070215
Date:28.08.2003
Language:DE
[2003/35]
Type: A1 Application with search report 
No.:EP1478338
Date:24.11.2004
Language:DE
The application published by WIPO in one of the EPO official languages on 28.08.2003 takes the place of the publication of the European patent application.
[2004/48]
Type: B1 Patent specification 
No.:EP1478338
Date:06.07.2005
Language:DE
[2005/27]
Search report(s)International search report - published on:EP28.08.2003
ClassificationIPC:A61K9/00
[2004/48]
CPC:
A61K9/0075 (EP); A61K9/00 (KR); A61K31/517 (EP,KR);
A61K9/1688 (EP); A61P25/06 (EP); B82Y5/00 (KR)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SI,   SK,   TR [2004/48]
Extension statesALNot yet paid
LT20.09.2004
LV20.09.2004
MKNot yet paid
RO20.09.2004
TitleGerman:PULVERINHALATIVUM, ENTHALTEND DEN CGRP-ANTAGONISTEN BIBN4096 UND VERFAHREN ZU DESSEN HERSTELLUNG[2004/48]
English:POWDER INHALATION CONTAINING CGRP-ANTAGONIST BIBN4096 AND METHOD FOR THE PRODUCTION THEREOF[2004/48]
French:POUDRE D'INHALATION CONTENANT L'ANTAGONISTE BIBN4096 DE CGRP ET PROCEDE DE FABRICATION[2004/48]
Entry into regional phase20.09.2004National basic fee paid 
20.09.2004Designation fee(s) paid 
20.09.2004Examination fee paid 
Examination procedure12.08.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
20.09.2004Examination requested  [2004/48]
21.12.2004Communication of intention to grant the patent
02.05.2005Fee for grant paid
02.05.2005Fee for publishing/printing paid
Opposition(s)07.04.2006No opposition filed within time limit [2006/24]
Fees paidRenewal fee
28.02.2005Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY06.07.2005
CZ06.07.2005
EE06.07.2005
FI06.07.2005
IE06.07.2005
NL06.07.2005
SI06.07.2005
SK06.07.2005
TR06.07.2005
BG06.10.2005
DK06.10.2005
GR06.10.2005
SE06.10.2005
PT12.12.2005
HU07.01.2006
BE28.02.2006
LU28.02.2006
MC28.02.2006
[2009/02]
Former [2007/14]CZ06.07.2005
EE06.07.2005
FI06.07.2005
IE06.07.2005
NL06.07.2005
SI06.07.2005
SK06.07.2005
TR06.07.2005
BG06.10.2005
DK06.10.2005
GR06.10.2005
SE06.10.2005
PT12.12.2005
HU07.01.2006
BE28.02.2006
LU28.02.2006
MC28.02.2006
Former [2006/52]CZ06.07.2005
FI06.07.2005
IE06.07.2005
NL06.07.2005
SI06.07.2005
SK06.07.2005
TR06.07.2005
BG06.10.2005
DK06.10.2005
GR06.10.2005
SE06.10.2005
PT12.12.2005
MC28.02.2006
Former [2006/44]CZ06.07.2005
FI06.07.2005
IE06.07.2005
NL06.07.2005
SI06.07.2005
SK06.07.2005
BG06.10.2005
DK06.10.2005
GR06.10.2005
SE06.10.2005
PT12.12.2005
MC28.02.2006
Former [2006/29]CZ06.07.2005
FI06.07.2005
IE06.07.2005
NL06.07.2005
SI06.07.2005
SK06.07.2005
BG06.10.2005
DK06.10.2005
GR06.10.2005
SE06.10.2005
PT12.12.2005
Former [2006/26]CZ06.07.2005
FI06.07.2005
IE06.07.2005
NL06.07.2005
SI06.07.2005
BG06.10.2005
DK06.10.2005
GR06.10.2005
SE06.10.2005
PT12.12.2005
Former [2006/25]FI06.07.2005
IE06.07.2005
NL06.07.2005
SI06.07.2005
BG06.10.2005
GR06.10.2005
SE06.10.2005
PT12.12.2005
Former [2006/22]FI06.07.2005
NL06.07.2005
SI06.07.2005
BG06.10.2005
GR06.10.2005
SE06.10.2005
PT12.12.2005
Former [2006/14]FI06.07.2005
SI06.07.2005
BG06.10.2005
GR06.10.2005
SE06.10.2005
PT12.12.2005
Former [2006/13]FI06.07.2005
SI06.07.2005
BG06.10.2005
SE06.10.2005
Cited inInternational search[DA]DE1792207  (FISONS PHARMACEUTICALS LTD) [DA] 1-14* claims 1,3 *;
 [XA]WO0110425  (BOEHRINGER INGELHEIM PHARMA [DE], et al) [X] 1-3 * example 1 * * example 1 * [A] 4-12;
 [A]WO0132144  (INHALE THERAPEUTIC SYST [US], et al) [A] 1-14 * claims 2,15-18 *;
 [PXA]DE10139410  (BOEHRINGER INGELHEIM PHARMA [DE]) [PX] 1-3 * example 2 * * example 2 * [PA] 4-12
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.